Acral mutilation syndrome (AMS) is an uncommon inherited neurological disorder in dogs that results in affected pets compulsively licking, biting, and grooming their paws and limbs. Because these dogs lose normal sensation and pain feedback in these areas, they don't realize when they injure themselves, causing serious self-inflicted wounds.
Though AMS might seem behavioral, it is actually a polyneuropathy impacting sensory nerves. Dogs with AMS may chew off claws or parts of their paw pads and toes. Given the severe impact on affected dogs' health and well-being, breeding these dogs is strongly discouraged to stop the gene from spreading.
Awareness of AMS's genetic roots has prompted organizations like the American Kennel Club and major U.S. veterinary associations to develop genetic screening programs. These initiatives help breeders identify carriers or affected dogs, supporting informed, ethical breeding decisions to reduce AMS incidence forward.
The first indication of AMS typically involves intense, repetitive licking and chewing of the feet and lower limbs, which often leads to raw, bleeding sores. Puppies with AMS might be noticeably smaller compared to their siblings and show symptoms early, sometimes even before weaning. Because they lack normal pain perception, they can damage themselves to the point of losing claws, developing ulcerated footpads, or suffering bone fractures without obvious signs of pain or limping.
This self-mutilation stems from the dog's inability to feel normal touch or pain in the affected areas, which worsens as the dog persists in biting without the usual pain deterrent. Several limbs may be involved, yet affected dogs often continue to walk without difficulty.
AMS is chiefly observed in certain pedigree dog breeds carrying inherited gene mutations affecting nerve signaling. In the U.S., breeds most frequently linked to AMS include Cocker Spaniel puppies, English Setter puppies, German Shorthaired Pointer puppies, and Miniature Schnauzer puppies. These breeds show symptoms at a young age, often within the puppy stage before leaving their litter.
AMS follows an autosomal recessive inheritance pattern. To develop AMS, a dog must inherit two copies of the defective gene—one from each parent. Dogs possessing only one mutated gene are carriers; they do not display symptoms but can pass the mutation on to their offspring.
Genetic screening for AMS is highly recommended for breeders to help avoid producing affected puppies. The process involves a simple DNA collection through either a cheek swab or blood sample submitted to approved U.S. diagnostic laboratories.
Testing focuses on the breeds at risk and results classify dogs as Clear (no mutation present), Carrier (one copy of the mutation), or Affected (two copies). These statuses are typically recorded in breed health registries to promote transparency and assist breeders in making informed pairing decisions.
If you're planning to welcome a susceptible breed into your home, work exclusively with responsible breeders who conduct thorough health screenings, including AMS tests. Responsible breeders are transparent about health results and actively strive to diminish hereditary diseases.
For current dog owners, if your pet shows excessive licking or self-injury around the paws or limbs, it’s important to promptly schedule a veterinary consultation for diagnosis and compassionate management of injuries or infections.
Acral mutilation syndrome is a troubling inherited condition affecting nerve sensation in specific dog breeds, leading to severe self-harm. Genetic testing is an essential tool for breeders to prevent the propagation of AMS within the breed population. Being informed about hereditary health risks and choosing ethically bred dogs supports better health and welfare for future canine generations.
Always consult your veterinarian or your breed’s parent club for details about AMS genetic testing, and support breeding programs that prioritize animal welfare in the United States.